Amalgent Therapeutics, LLC — Form D
Amalgent Therapeutics, LLC of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-20. The offering totals $1.0M, of which $200K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-04-20
- Form: D
- Accession: 0001924038-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $200K
- Remaining: $800K
- Investors: 1
- Date of first sale: 2022-04-04
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-442672
Issuer
- Name: Amalgent Therapeutics, LLC
- CIK: 0001924038
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 206 PEBBLE SPRINGS ROAD, CHAPEL HILL, NC, 27514
- Phone: 919-923-1846
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Malcolm A Meyn | Director | Chapel Hill, NC |
| Sam A Tetlow | Director | Chapel Hill, NC |
| Malcolm A Meyn | Executive Officer | Chapel Hill, NC |
More